Pharmacokinetic models of morphine and its metabolites in neonates: Systematic comparisons of models from the literature, and development of a new meta-model

KR Knosgaard, DJR (David John Richard) Foster, M Kreilgaard, E Sverrisdottir, RN Upton, John van den Anker

Research output: Contribution to journalArticleAcademicpeer-review

27 Citations (Scopus)


Morphine is commonly used for pain management in preterm neonates. The aims of this study were to compare published models of neonatal pharmacokinetics of morphine and its metabolites with a new dataset, and to combine the characteristics of the best predictive models to design a meta-model for morphine and its metabolites in preterm neonates. Moreovdr, the concentration-analgesia relationship for morphine in this clinical setting was also investigated. A population of 30 preterm neonates (gestational age: 23-32 weeks) received a loading dose of morphine (50-100 mu g/kg), followed by a continuous infusion (5-10 mu g/kg/h) until analgesia was no longer required. Pain was assessed using the Premature Infant Pain Profile. Five published population models were compared using numerical and graphical tests of goodness-of-fit and predictive performance. Population modelling was conducted using NONMEM (R) and the $PRIOR subroutine to describe the time-course of plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide, and the concentration-analgesia relationship for morphine. No published model adequately described morphine concentrations in this new dataset. Previously published population pharmacokinetic models of morphine, morphine-3-glucuronide, and morphine-6-glucuronide were combined into a meta-model. The meta-model provided an adequate description of the time-course of morphine and the concentrations of its metabolites in preterm neonates. Allometric weight scaling was applied to all clearance and volume terms. Maturation of morphine clearance was described as a function of postmenstrual age, while maturation of metabolite elimination was described as a function of postnatal age. A clear relationship between morphine concentrations and pain score was not established. (C) 2016 Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)117-130
Number of pages14
JournalEuropean Journal of Pharmaceutical Sciences
Publication statusPublished - 2016

Research programs

  • EMC MGC-02-53-01-A

Cite this